Clinical trials
Withdrawn Diabetes Mellitus, Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
111 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 10 |
| 2019 | 7 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 111 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Recherches Cliniques de Montreal | 6 |
| Medtronic MiniMed, Inc. | 5 |
| Vanderbilt University | 4 |
| Eli Lilly and Company | 3 |
| Stanford University | 3 |
| Children's Mercy Hospital Kansas City | 2 |
| Emory University | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 111 |
| Diabetes Mellitus | 25 |
| Diabetes Mellitus, Type 2 | 17 |
| Hypoglycemia | 16 |
| Insulin Resistance | 8 |
| Hyperglycemia | 4 |
| Autoimmune Diseases | 3 |
| Endocrine System Diseases | 3 |
| Diabetic Retinopathy | 2 |
| Foot Ulcer | 2 |
Trials
Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.
11 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.